FATMA IBRAHIM SONBOL, MAHA ABD EL FATTAH KHALIL, ABDELFATTAH BADR MOHAMED, SAMEH SAMIR ALI

Correlation between antibiotic resistance and virulence ofPseudomonas aeruginosa clinical isolates

Background/aim: Virulent Pseudomonas aeruginosa is frequently life-threatening and often challenging to treat, and the emergence of multidrug-resistant isolates presents a critical problem for patients. The aim of the study was concerned with molecular analysis of the virulence factors and antimicrobial resistance profile of multidrug-resistant P. aeruginosa (MDRPA). Materials and methods: Out of 44 MDRPA isolates, 12 isolates representing different resistance profiles and sources of samples were selected for further molecular studies. Polymerase chain reaction (PCR) approaches were applied to identify the genes implicated in antimicrobial resistance or virulence factors in the selected MDRPA isolates. Results: Multidrug-resistance (pstS), Ã-lactamase (IMP7, IMP10, IMP13, and IMP25), and extended spectrum Ã-lactamase (blaOXA50) genes were detected in all of the selected MDRPA isolates. However, only 4 (33%) MDRPA isolates were positive for the presence of the extended spectrum Ã-lactamase (blaOXA2) gene. Furthermore, the hemolytic phospholipase C precursor gene (plcH) was detected in all PCR products of the tested MDRPA isolates while the exotoxin A (toxA) gene was absent. Other virulence genes were detected with variable percentage in tested isolates. Conclusion: The statistical analysis revealed a significantly positive correlation (r = 0.779, P = 0.002) between virulence factors and antimicrobial resistance marker profiles of the tested MDRPA isolates.

Anahtar Kelimeler:

Multidrug-resistant Pseudomonas aeruginosa, antibiotic, virulence factors, genes, polymerase chain reaction

Correlation between antibiotic resistance and virulence ofPseudomonas aeruginosa clinical isolates

Keywords:

Multidrug-resistant Pseudomonas aeruginosa, antibiotic, virulence factors, genes, polymerase chain reaction,

PDF

___

Obritsch MD, Fish DN, MacLaren R, Jung R. Nosocomial infections due to multidrug-resistant Pseudomonas aeruginosa: epidemiology and treatment options. Pharmacotherapy 2005; 10: 1353–1364. 2. Story RM, Weber IT, Steitz TA. The structure of the E. coli recA protein monomer and polymer. Nature 1992; 355: 318–325. 3.
Shanooba MP, Vishnu JG, Nitin VG, Sandip SP. Antibacterial
targets in Pseudomonas aeruginosa. Int J Pharma Appl 2011; 2159–2164. 4.
Zourob M, Elwary S, Turner A, editors. Principles of
Bacterial Detection: Biosensors, Recognition Receptors and
Rossolini GM, Mantengoli E. Treatment and control of severe infections caused by multiresistant Pseudomonas aeruginosa. Clin Microbiol Infect 2005; 11: 17–32.
Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning. A Laboratory Manual. Cold Spring Harbor, NY, USA: Cold Spring Harbor Laboratory Press; 1989.
Crăciunaş C, Butiuc-Keul A, Flonta M, Brad A, Sigarteu M. Application of molecular techniques to the study of Pseudomonas aeruginosa clinical isolate in Cluj-Napoca, Romania. Analele Universităţii din Oradea-Fascicula Biologie 2010; XVII: 243–247.
Lanotte P, Watt S, Mereghetti L, Dartiguelongue N, Rastegar- Lari A, Quentin R. Genetic features of Pseudomonas aeruginosa isolates from cystic fibrosis patients compared with those isolates from other origins. J Med Microbiol 2004; 53: 73–81.
Strateva T, Petrova G, Perenovsk P, Mitov I. Bulgarian cystic fibrosis Pseudomonas aeruginosa isolates: antimicrobial susceptibility and neuraminidase-encoding gene distribution. J Med Microbiol 2009; 58: 690–692.
Stover CK, Pham XQ, Erwin AL, Mizoguchi SD, Warrener P, Hickey MJ, Brinkman FSL, Hufnagle WO, Kowalik DJ, Lagrou M et al. Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature 2000; 406: 959–964.
Yah SC, Eghafona NO, Enabulele IO. Prevalence of plasmids mediated Pseudomonas aeruginosa resistant genes from burn wound patients at the University of Benin Teaching Hospital Benin City, Nigeria J Biomed Sci 2006; 5: 61–68.
Daini OA, Onyeaghala CG. Plasmid-mediated aminoglycoside resistance of clinical isolates of Pseudomonas aeruginosa. Global Advanced Research Journal of Microbiology 2012; 1: 52–56.
Livermore DM, Williams JD. β-Lactams: mode of action and mechanisms of bacterial resistance. In: Lorian V, editor. Antibiotics in Laboratory Medicine. 4th ed. Baltimore, MD, USA: Williams and Wilkins; 1996. pp. 502–578.
Ambler RP, Coulson AF, Frere JM, Joris B, Waley SG. A standard numbering scheme for the class A beta-lactamase. Biochem J 1991; 276: 269–270.
Majiduddin FK, Materon IC, Palzkill TG. Molecular analysis of beta-lactamase structure and function. Int J Med Microbiol 2002; 292: 127–137.
Ledent P, Raquet X, Joris B, Van Beeaumen J, Frere JM. A comparative study of class D β-lactamases. Biochem J 1993; 292: 555–562.
Aktas Z, Poirel L, Salcioglu M, Ozcan PE, Midilli K, Bal C, Ang O, Nordmann P. PER-1- and OXA-10-like β-lactamases in ceftazidime-resistant Pseudomonas aeruginosa isolates from intensive care unit patients in Istanbul, Turkey. Clin Microbiol Infect 2005; 11: 193–198.
De Champs C, Chanal C, Sirot D, Baraduc R, Romaszko JP, Bonnet R, Plaidy A, Boyer M, Carroy E, Gbadamassi MC et al. Frequency and diversity of class A extended-spectrum β-lactamases in hospitals of the Auvergne, France: a 2 year prospective study. J Antimicrob Chemoth 2004; 54: 634–639.
Empel J, Filczak K, Mrówka A, Hryniewicz W, Livermore DM, Gniadkowski M. Outbreak of Pseudomonas aeruginosa infections with PER-1 extended-spectrum β-lactamase in Warsaw, Poland: further evidence for an international clonal complex. J Clin Microbiol 2007; 45: 2829–2834.
Osano E, Arakawa Y, Wacharotayankun R, Ohta M, Horii T, Ito H, Yoshimura F, Kato N. Molecular characterization of an enterobacterial metallo-β-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance. Antimicrob Agent Chemother 1994; 38: 71–78.
Yamano Y, Nishikawa T, Fujimura T, Yutsudou T, Tsuji M, Miwa H. Occurrence of PER-1-producing clinical isolates of Pseudomonas aeruginosa in Japan and their susceptibility to doripenem. J Antibiotics 2006; 59: 791–796.
Toleman MA, Rolston K, Jones RN, Walsh TR. blaVIM-7, an evolutionarily distinct metallo-β-lactamase gene in a Pseudomonas aeruginosa isolate from the United States. Antimicrob Agent Chemother 2004; 48: 329–332.
Quinteira S, Sousa JC, Peixe L. Characterization of In100, a new integron carrying a metallo-β-lactamase and carbenicillinase from Pseudomonas aeruginosa. Antimicrob Agent Chemother 2005; 49: 451–453.
Walsh TR, Toleman MA, Poirel L, Nordmann P. Metallo-beta- lactamases: the quiet before the storm? Clin Microbiol Rev 2005; 18: 306–325.
Poirel L, Nordmann P. Carbapenem resistance in Acinetobacter baumannii: mechanisms and epidemiology. Clin Microbiol Infect 2006; 12: 826–836.
Gibb AP, Tribuddharat C, Moore RA, Woodford N. Nosocomial outbreak of carbapenem-resistant Pseudomonas aeruginosa with a new blaIMP allele, blaIMP-7. Antimicrob Agent Chemother 2002; 46: 255–258.
Morales R, Berna A, Carpentier P, Contreras-Martel C, Renault F, Nicodeme M, Chesne-Seck ML, Bernier F, Dupuy J, Schaeffer C et al. Serendipitous discovery and X-ray structure of a human phosphate binding apolipoprotein. Structure 2006; 14: 601–609.
Zaborina O, Holbrook C, Chen Y, Long J, Zaborin A, Morozova I, Fernandez H, Wang Y, Turner JR, Alverdy JC. Structure– function aspects of PstS in multi-drug–resistant Pseudomonas aeruginosa. PLoS Pathog 2008; 4: e43.
Bradbury RS, Roddam LF, Merritt A, Champion AC. Virulence gene distribution in clinical nosocomial and environmental isolates of Pseudomonas aeruginosa. J Med Microbiol 2010; 59: 881–890.
Mitov I, Strateva T, Markova B. Prevalence of virulence genes among Bulgarian nosocomial and cystic fibrosis isolates of Pseudomonas aeruginosa. Brazilian J Microbiol 2010; 41: 588– 595.
Schulert GS, Feltman H, Rabin SD, Martin CG, Battle SE, Rello J, Hauser AR. Secretion of the toxin ExoU is a marker for highly virulent Pseudomonas aeruginosa isolates obtained from patients with hospitals-acquired pneumonia. J Infect Dis 2003; 188: 1695–1706.
Woodford N, Norrison D, Johnson AP, Briant V, George RC, Cookson B. Application of DNA probers for rRNA and vanA genes to investigation of nosocomial cluster of vancomycin- resistant enterococci. J Clin Microbiol 1993; 31: 653–658.
Bergogne-Berzin E. What is the source of antibiotic resistance? J Med Microbiol 1997; 46: 461–464.
Sexton DJ. The impact of antimicrobial resistance on empiric selection and antimicrobial use in clinical practice. J Med Liban 2000; 48: 215–220.